Novartis | NVS - 债务





债务 更改 日
AbbVie USD 72.86B 5.36B 2026-03
Amgen USD 57.32B 2.72B 2026-03
AstraZeneca USD 32.24B 1.68B 2026-06
Bausch Health Companies USD 20.78B 16M 2026-06
Biogen USD 8.09B 1.53B 2026-06
Bristol-Myers Squibb USD 46.43B 711M 2026-03
Canopy Growth CAD 278.71M 19.38M 2026-03
Corcept Therapeutics USD 9.64M 3.53M 2026-03
Drreddys Laboratories INR 77.34B 9.61B 2026-03
Eli Lilly USD 43.37B 867M 2026-03
Gilead Sciences USD 22.17B 2.76B 2026-03
GlaxoSmithKline GBP 19.06B 1.34B 2026-03
Glaxosmithkline GBP 19.06B 1.31B 2026-03
J&J USD 54.99B 7.05B 2026-03
Merck USD 49.12B 222M 2026-03
Novartis USD 49.01B 2.02B 2026-06
Novartis USD 47B 14.98B 2026-03
Pacira USD 363.12M 4.53M 2026-06
Perrigo USD 3.63B 7.7M 2026-03
Pfizer USD 63.73B 231M 2026-03
Phibro Animal Health USD 474.17M 730K 2024-09
Prestige Brands USD 1.05B 33.86M 2026-03
Roche Holding CHF 33.03B 1.41B 2025-06
Sanofi EUR 23.58B 3.56B 2026-06
Sanofi EUR 20.02B 1.73B 2026-03
Supernus Pharmaceuticals USD 40.9M 74K 2026-03
Zoetis USD 9.24B 0 2026-03